Asahi Kasei Signs MOU With Power to Hydrogen to Accelerate Commercialization of AEM Water Electrolysis for Clean Hydrogen ProductionBusiness Wire • Wednesday
Asahi Kasei Therapeutics Announces FDA Approval of HOVILPRI® (pritelivir) Tablets for Mucocutaneous HSV Lesions Refractory (With or Without Resistance) to Standard Antiviral Treatment in Immunocompromised AdultsBusiness Wire • 10/09/26
Asahi Kasei Microdevices Holds IEEE Milestone Commemoration Ceremony in Nobeoka for the Commercialization of Thin-Film Hall ElementsBusiness Wire • 10/09/26
Asahi Kasei Therapeutics Announces First Patient Dosed in Phase 2a Trial of AIC468 for BK Virus Infection in Kidney Transplant RecipientsBusiness Wire • 10/08/26
Asahi Kasei to Integrate Global Pharmaceutical Brand Under Asahi Kasei TherapeuticsBusiness Wire • 09/29/26
Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop to Improve Efficiency and Consistency in Gene Therapy ManufacturingBusiness Wire • 09/15/26
Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company's 40-Year North American Battery Separator StrategyBusiness Wire • 08/26/26
Asahi Kasei Develops Novel Lithium Pre-doping Technology to Raise Energy Density and Lower Cost of Silicon-rich Lithium-ion BatteriesBusiness Wire • 08/20/26
Asahi Kasei's Capacity Expansion for Water Electrolysis and Chlor‑Alkali Equipment in Kawasaki Awarded Regional Economic IncentivesBusiness Wire • 08/19/26
Asahi Kasei Enters First License Agreement for Production and Sale of Acetolyte™ Novel Electrolyte in ChinaBusiness Wire • 08/06/26
Asahi Kasei Microdevices Begins Mass Production of Camera‑less Modules for Detection of Falls, Vital Signs, Posture, and PositionBusiness Wire • 07/15/26
Asahi Kasei's Novel Forward Osmosis–Membrane Distillation System Installed at Peptistar's API Manufacturing Facility for Reduced Pharmaceutical Manufacturing TimeBusiness Wire • 06/25/26
EAS Batteries Starts Sales of Ultra-High-Power Cell Using Asahi Kasei's Novel Electrolyte Acetolyte™Business Wire • 06/02/26
Asahi Kasei Life Science Acquires License for Novel Antibody-Drug Conjugate Technology from The Noguchi Institute – A Major Milestone for More Efficient and Safer Cancer TreatmentsBusiness Wire • 05/27/26
Asahi Kasei Develops Novel Photosensitive Polyimide Film for Advanced Panel-Level Semiconductor PackagingBusiness Wire • 05/21/26
Asahi Kasei Microdevices Debuts AK491x Premium Audio Op Amps at HIGH END Vienna 2026Business Wire • 05/20/26
Asahi Kasei Optimizes Material Portfolio Through Supply Realignment by FY2030Business Wire • 05/12/26
5 Undervalued Price-to-Sales Stocks That Could Deliver Outsized GainsZacks Investment Research • 04/28/26
Asahi Kasei Completes Acquisition of Aicuris to Advance Its Global Pharmaceutical StrategyBusiness Wire • 04/20/26
Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune DiseasesBusiness Wire • 04/20/26
Asahi Kasei (AHKSY) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 04/16/26